A critical breakthrough in cancer research is emerging with the use of VHH fragments to reactivate mutated p53. This vital malignant suppressor protein is frequently disabled in various kinds of cancer, causing https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research